Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
- 1 December 2001
- journal article
- review article
- Vol. 5 (12) , 1078-9
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: